RUNX1 and acute myeloid leukemia: The AML samples represented the subgroups NPM1-mutated, AML-MR, TP53-mutated, CBFB::MYH11, RUNX1::RUNX1T1, AML without class-defining mutations, and AML meeting criteria for two subgroups.